Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cockroach Sublingual Immunotherapy in Sensitive Children
NCT01380327Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2011
- Primary completion
- Jun 2012
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of blattella germanica allergenic extract in asthma and perennial allergic rhinitis (PAR) (3 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Change in German Cockroach-Specific Serum IgE Over Time at 3 months. Started May 2011; status: completed.
02
Drugs
blattella germanica allergenic extract
03
Conditions
asthmaperennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT01380327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01380327.